ArticleEBioMedicine2024

Discovery of a peptide proteolysis-targeting chimera (PROTAC) drug of p300 for prostate cancer therapy.

Dize Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.